Management and outcomes of type 2 diabetes in global Asian populations

Please join us …

When: Tuesday, February 7, 2017, 12–1 p.m.

Where: ICES, G-Wing, Conference Centre (Sunnybrook Health Sciences Centre)

Who: Dr. Calvin Ke, MD, FRCPC; PGY-5, Endocrinology and Metabolism, University of Toronto; MSc to PhD Transfer Candidate, Clinical Epidemiology & Health Care Research, Institute of Health Policy, Management and Evaluation, University of Toronto.

Topic: Management and outcomes of type 2 diabetes in global Asian populations (MSc to PhD transfer defence)

Learning objectives

1. Determining whether diabetes increases the risk of cardiovascular mortality in India
2. Investigating whether DM2 diagnosis within the young-onset period (age 20 to 40 years) predicts increased cardiovascular complications compared to those diagnosed ≥40 years of age among South Asian, Chinese, and other patients with DM2
3. Evaluating real-world effectiveness of SGLT2 inhibitors in Chinese patients.

 

Calvin Ke